Drug Type Small interfering RNA |
Synonyms Aerosolised ALN-RSV01, Intranasal ALN-RSV01, ALN RSV01 + [1] |
Target- |
Mechanism RNA interference |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
KEGG | Wiki | ATC | Drug Bank |
---|---|---|---|
- | - | - |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Respiratory Syncytial Virus Infections | Phase 2 | US | 01 Jul 2007 |
NCT01065935 (Pubmed) Manual | Phase 2 | 77 | njkvopfzou(sqawutmzvo) = vfnahaoaim xipxvjeatz (ucrorvypnh ) | Positive | 01 Feb 2016 | ||
Placebo | njkvopfzou(sqawutmzvo) = yqyyviiznn xipxvjeatz (ucrorvypnh ) | ||||||
Phase 2 | 87 | bbqwupucss(syoouuswit) = oiwlbgzmpl vbbrkmlwkd (fcuokghuly ) | Positive | 01 Sep 2012 | |||
Placebo | bbqwupucss(syoouuswit) = cptjlbfqlg vbbrkmlwkd (fcuokghuly ) |